Perinatal maternal administration of lactobacillus paracasei NCC 2461 prevents allergic inflammation in a mouse model of birch pollen allergy

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Schabussova, Irma ^a   Hufnagl, Karin ^a   Tang, Mimi L K ^b,c   Hoflehner, Elisabeth ^a   Wagner, Angelika ^a   Loupal, Gerhard ^d   Nutten, Sophie ^e   Zuercher, Adrian ^f   Mercenier, Annick ^e   Wiedermann, Ursula ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^d UNIVERSITY OF VETERINARY MEDICINE   (Austria)

^e NESTLÉ RESEARCH CENTER   (Switzerland)

^f ZLB Behring AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CONCANAVALIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERLEUKIN 4; INTERLEUKIN 5; MESSENGER RNA; POLLEN EXTRACT; PROBIOTIC AGENT; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

ALLERGIC AIRWAY INFLAMMATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; FEMALE; FOXP3 GENE; GENE; GESTATION PERIOD; GESTATIONAL AGE; INFLAMMATORY INFILTRATE; LACTATION INHIBITION; LACTOBACILLUS PARACASEI; LUNG INFILTRATE; LUNG LAVAGE; MESENTERY LYMPH NODE; MOUSE; NONHUMAN; PERINATAL PERIOD; POLLEN ALLERGY; PROGENY; SPLEEN CELL; TISSUE CULTURE CELL; UPREGULATION;

ANIMALS; ANTIGENS, PLANT; BETULA; CELL PROLIFERATION; CELLS, CULTURED; DISEASE MODELS, ANIMAL; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; LACTATION; LACTOBACILLUS; LUNG; MATERNAL-FETAL EXCHANGE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; POLLEN; PREGNANCY; PROBIOTICS; RHINITIS, ALLERGIC, SEASONAL; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; UP-REGULATION;

LACTOBACILLUS PARACASEI; MUS;

EID: 84863658993     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0040271     Document Type: Article

References (39)

1. Moffatt MF, Kabesch M, Liang L, Dixon AL, Strachan D, et al. (2007) Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma. Nature 448: 470-473.
2. Vercelli D, (2008) Discovering susceptibility genes for asthma and allergy. Nat Rev Immunol 8: 169-182.
3. Savino F, Cresi F, Pautasso S, Palumeri E, Tullio V, et al. (2004) Intestinal microflora in breastfed colicky and non-colicky infants. Acta Paediatr 93: 825-829.
4. Savino F, Roana J, Mandras N, Tarasco V, Locatelli E, et al. (2011) Faecal microbiota in breast-fed infants after antibiotic therapy. Acta Paediatr 100: 75-78.
5. Bjorksten B, Naaber P, Sepp E, Mikelsaar M, (1999) The intestinal microflora in allergic Estonian and Swedish 2-year-old children. Clin Exp Allergy 29: 342-346.
6. Kalliomaki M, Kirjavainen P, Eerola E, Kero P, Salminen S, et al. (2001) Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J Allergy Clin Immunol 107: 129-134.
7. Suzuki S, Shimojo N, Tajiri Y, Kumemura M, Kohno Y, (2007) Differences in the composition of intestinal Bifidobacterium species and the development of allergic diseases in infants in rural Japan. Clin Exp Allergy 37: 506-511.
8. Penders J, Thijs C, van den Brandt PA, Kummeling I, Snijders B, et al. (2007) Gut microbiota composition and development of atopic manifestations in infancy: the KOALA Birth Cohort Study. Gut 56: 661-667.
9. Bisgaard H, Li N, Bonnelykke K, Chawes BL, Skov T, et al. (2011) Reduced diversity of the intestinal microbiota during infancy is associated with increased risk of allergic disease at school age. J Allergy Clin Immunol. 128: 646-52.
10. Bjorksten B, Sepp E, Julge K, Voor T, Mikelsaar M, (2001) Allergy development and the intestinal microflora during the first year of life. J Allergy Clin Immunol 108: 516-520.
11. Holt PG, Upham JW, Sly PD, (2005) Contemporaneous maturation of immunologic and respiratory functions during early childhood: implications for development of asthma prevention strategies. J Allergy Clin Immunol 116: 16-24; quiz 25.
12. Taussig LM, Wright AL, Holberg CJ, Halonen M, Morgan WJ, et al. (2003) Tucson Children's Respiratory Study: 1980 to present. J Allergy Clin Immunol 111: 661-675; quiz 676.
13. Tang ML, Lahtinen SJ, Boyle RJ, (2010) Probiotics and prebiotics: clinical effects in allergic disease. Curr Opin Pediatr 22: 626-634.
14. Daniel C, Repa A, Wild C, Pollak A, Pot B, et al. (2006) Modulation of allergic immune responses by mucosal application of recombinant lactic acid bacteria producing the major birch pollen allergen Bet v 1. Allergy 61: 812-819.
15. Schabussova I, Hufnagl K, Wild C, Nutten S, Zuercher AW, et al. (2011) Distinctive anti-allergy properties of two probiotic bacterial strains in a mouse model of allergic poly-sensitization. Vaccine 29: 1981-1990.
16. Schwarzer M, Repa A, Daniel C, Schabussova I, Hrncir T, et al. (2011) Neonatal colonization of mice with Lactobacillus plantarum producing the aeroallergen Bet v 1 biases towards Th1 and T-regulatory responses upon systemic sensitization. Allergy 66: 368-375.
17. von der Weid T, Bulliard C, Schiffrin EJ, (2001) Induction by a lactic acid bacterium of a population of CD4(+) T cells with low proliferative capacity that produce transforming growth factor beta and interleukin-10. Clin Diagn Lab Immunol 8: 695-701.
18. Wagner A, Forster-Waldl E, Garner-Spitzer E, Schabussova I, Kundi M, et al. (2009) Immunoregulation by Toxoplasma gondii infection prevents allergic immune responses in mice. Int J Parasitol 39: 465-472.
19. Winkler B, Baier K, Wagner S, Repa A, Eichler HG, et al. (2002) Mucosal tolerance as therapy of type I allergy: intranasal application of recombinant Bet v 1, the major birch pollen allergen, leads to the suppression of allergic immune responses and airway inflammation in sensitized mice. Clin Exp Allergy 32: 30-36.
20. Lutz MB, Kukutsch N, Ogilvie AL, Rossner S, Koch F, et al. (1999) An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods 223: 77-92.
21. Smits HH, Gloudemans AK, van Nimwegen M, Willart MA, Soullie T, et al. (2009) Cholera toxin B suppresses allergic inflammation through induction of secretory IgA. Mucosal Immunol. 2: 331-9.
22. Corthesy B, Gaskins HR, Mercenier A, (2007) Cross-talk between probiotic bacteria and the host immune system. J Nutr 137: 781S-790S.
23. Dotterud CK, Storro O, Johnsen R, Oien T, (2010) Probiotics in pregnant women to prevent allergic disease: a randomized, double-blind trial. Br J Dermatol 163: 616-623.
24. Feleszko W, Jaworska J, Rha RD, Steinhausen S, Avagyan A, et al. (2007) Probiotic-induced suppression of allergic sensitization and airway inflammation is associated with an increase of T regulatory-dependent mechanisms in a murine model of asthma. Clin Exp Allergy 37: 498-505.
25. Osborn DA, Sinn JK, (2007) Prebiotics in infants for prevention of allergic disease and food hypersensitivity. Cochrane Database Syst Rev.
26. Schaub B, Liu J, Hoppler S, Schleich I, Huehn J, et al. (2009) Maternal farm exposure modulates neonatal immune mechanisms through regulatory T cells. J Allergy Clin Immunol 123: 774-782 e775.
27. Brand S, Teich R, Dicke T, Harb H, Yildirim AO, et al. (2011) Epigenetic regulation in murine offspring as a novel mechanism for transmaternal asthma protection induced by microbes. J Allergy Clin Immunol. 128: 618-25.
28. Renz H, Conrad M, Brand S, Teich R, Garn H, et al. (2011) Allergic diseases, gene-environment interactions. Allergy 66: 10-12.
29. Renz H, von Mutius E, Brandtzaeg P, Cookson WO, Autenrieth IB, et al. (2011) Gene-environment interactions in chronic inflammatory disease. Nat Immunol 12: 273-277.
30. Blumer N, Sel S, Virna S, Patrascan CC, Zimmermann S, et al. (2007) Perinatal maternal application of Lactobacillus rhamnosus GG suppresses allergic airway inflammation in mouse offspring. Clin Exp Allergy 37: 348-357.
31. Latvala S, Miettinen M, Kekkonen RA, Korpela R, Julkunen I, (2011) Lactobacillus rhamnosus GG and Streptococcus thermophilus induce suppressor of cytokine signalling 3 (SOCS3) gene expression directly and indirectly via interleukin-10 in human primary macrophages. Clin Exp Immunol 165: 94-103.
32. Matsuzaki T, Yamazaki R, Hashimoto S, Yokokura T, (1998) The effect of oral feeding of Lactobacillus casei strain Shirota on immunoglobulin E production in mice. J Dairy Sci 81: 48-53.
33. Repa A, Grangette C, Daniel C, Hochreiter R, Hoffmann-Sommergruber K, et al. (2003) Mucosal co-application of lactic acid bacteria and allergen induces counter-regulatory immune responses in a murine model of birch pollen allergy. Vaccine 22: 87-95.
34. Martinez-Canavate A, Sierra S, Lara-Villoslada F, Romero J, Maldonado J, et al. (2009) A probiotic dairy product containing L. gasseri CECT5714 and L. coryniformis CECT5711 induces immunological changes in children suffering from allergy. Pediatr Allergy Immunol 20: 592-600.
35. de Roock S, van Elk M, van Dijk ME, Timmerman HM, Rijkers GT, et al. (2010) Lactic acid bacteria differ in their ability to induce functional regulatory T cells in humans. Clin Exp Allergy 40: 103-110.
36. Smits HH, Engering A, van der Kleij D, de Jong EC, Schipper K, et al. (2005) Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin. J Allergy Clin Immunol 115: 1260-1267.
37. Bortolatto J, Borducchi E, Rodriguez D, Keller AC, Faquim-Mauro E, et al. (2008) Toll-like receptor 4 agonists adsorbed to aluminium hydroxide adjuvant attenuate ovalbumin-specific allergic airway disease: role of MyD88 adaptor molecule and interleukin-12/interferon-gamma axis. Clin Exp Allergy 38: 1668-1679.
38. Velasco G, Campo M, Manrique OJ, Bellou A, He H, et al. (2005) Toll-like receptor 4 or 2 agonists decrease allergic inflammation. Am J Respir Cell Mol Biol 32: 218-224.
39. Conrad ML, Ferstl R, Teich R, Brand S, Blumer N, et al. (2009) Maternal TLR signaling is required for prenatal asthma protection by the nonpathogenic microbe Acinetobacter lwoffii F78. J Exp Med 206: 2869-2877.